Published January 2009 |
241 Pages |
95 Exhibits |
Forecasts Through 2014
The market for breast cancer detection, diagnosis, and treatment is well-developed in the U.S. and much of Europe. It has remained relatively under-developed in the Asia-Pacific region, however, although recent trends suggest that the opportunities for device manufacturers are improving, driven by the growing prevalence of breast disease in these countries.
In the U.S. and Europe, mammography is the standard of care for the early detection of breast cancer. Broader adoption is expected in...
Published January 2009 |
193 Pages |
106 Exhibits |
Forecasts Through 2015
Common conditions necessitating the use of neurosurgical products include hydrocephalus, aneurysms, arteriovenous malformations (AVMs), and pituitary and intracranial tumors. Intracranial shunts are often used to treat hydrocephalus. Aneurysms and AVMs may be treated using surgical clips or, increasingly, embolization products that may be deployed during endovascular procedures. Pituitary and intracranial tumors may be removed during open surgery, endoscopic surgery, or stereotactic radiosurgery...
Published January 2009 |
142 Pages |
61 Exhibits |
Forecasts Through 2013
Faced with escalating costs, acute hospitals require alternative care locations to accommodate the needs of extended-stay patients, who account for a substantial proportion of healthcare expenditures. Long-term acute care hospitals (LTACHs) are designed to accommodate the complex needs of these patients. These hospitals offer a range of services that includes mechanical ventilation and respiratory therapy, wound care, dialysis, and cardiopulmonary monitoring. LTACHs offer an attractive, niche...
Published January 2009 |
1763 Pages |
1 Exhibits |
This report includes details on over 1,000 companies that: presented at a 2009 LSI Emerging Medical Technologies Spotlight meeting or have been identified by LSI\'s in-house research team from 2004 thru 2009.
All companies include technology, market(s), key executive, and contact information.
Two- to three-page executive summaries are provided on most of the companies. Executive summaries typically include:
• Company Contact Information
• Company Overview (structure, size, year fo...
Published January 2009 |
262 Pages |
78 Exhibits |
Forecasts Through 2013
The tissue engineering and regenerative medicine market first emerged in the mid-1990\'s with the introduction of products for wound care and orthopaedic applications. The market has since expanded substantially, and approached $1.5 billion in 2008. The market is projected to grow at a 16.2% compound annual rate from 2008 through 2013, approaching $3.2 billion by 2013. This in-depth new market and technology report analyzes the following key topics:
Tissue engineering and regenerative me...
Published January 2009 |
241 Pages |
This 200+ page report includes details on 106 companies with technology applications in Spine who have presented at an LSI Emerging Medical Technologies Spotlight meeting or have been identified by LSI\'s in-house research team from 2004 thru 2009.
All companies include technology, market(s), key executive, and contact information.
Two- to three-page executive summaries are provided on all of the companies. Executive summaries typically include:
• Company Contact Information
• Compan...
Published January 2009 |
273 Pages |
104 Exhibits |
Forecasts Through 2015
All of our reports are available via individual purchase or as part of a subscription to our Medtech Pro platform, which includes a full library of reports.
Published January 2009 |
325 Pages |
109 Exhibits |
Forecasts Through 2015
All of our reports are available via individual purchase or as part of a subscription to our Medtech Pro platform, which includes a full library of reports.
Published January 2009 |
217 Pages |
80 Exhibits |
Forecasts Through 2015
All of our reports are available via individual purchase or as part of a subscription to our Medtech Pro platform, which includes a full library of reports.
Published January 2008 |
103 Pages |
40 Exhibits |
Forecasts Through 2013
To date, the growth of the U.S. market for artificial disc replacements has been disappointing. Initially, these technologies were expected to rapidly penetrate the market for spinal fusion patients due to their potential to: preserve motion, limit further degeneration, and avoid the need for fusion. Since the approval of DePuy Spines\' Charite for lumbar disc replacement in October 2004 however, growth has been restrained by reimbursement challenges, limited long-term data, and the need to use...
Published January 2008 |
185 Pages |
85 Exhibits |
Forecasts Through 2013
As analyzed in this report by Life Science Intelligence, the global market for vascular closure devices will reach nearly $1 billion by 2013. The market for vascular closure technologies, which includes implantable devices and external compression products,has traditionally been concentrated in the U.S. and Western Europe. These technologies are used to replace or augment manual compression following diagnostic catheterizations. By reducing time to hemostasis and facilitating more rapid recovery...
Published January 2008 |
150 Pages |
66 Exhibits |
Forecasts Through 2013
According to this report, the $1.2 billion 2008 global market for products used to monitor and treat neonatal and perinatal patients will grow at a CAGR of 5.2% reaching over $1.5 billion by 2013.
Growth in Asia-Pacific and other international markets will be driven by expanding populations and increasing birth rates, greater demand for these products, and the growing availability of low-cost or locally manufactured technologies. Developing countries account for the vast majority of annual b...
Published January 2008 |
244 Pages |
98 Exhibits |
Forecasts Through 2013
All of our reports are available via individual purchase or as part of a subscription to our Medtech Pro platform, which includes a full library of reports.
Published January 2007 |
244 Pages |
96 Exhibits |
Forecasts Through 2012
The breast disease diagnosis and therapy markets are poised for substantial and sustainable growth, according to this new report from Life Science Intelligence (LSI). The report, Breast Disease Diagnosis and Therapy Markets, 2007, finds that the $550 million U.S. digital mammography segment is expected to grow more than 50% annually during the next 3 years as digital technology replaces analog. In addition, the $167 million US vacuum-assisted biopsy segment will also experience dramatic growth r...
Published January 2007 |
505 Pages |
159 Exhibits |
Forecasts Through 2011
All of our reports are available via individual purchase or as part of a subscription to our Medtech Pro platform, which includes a full library of reports.
